The results showed that the concentrations of CSF MMP2, MMP9, sICAM, sVCAM, IL-1β, IL-17A and IFN-γ were significantly increased in IIDD and CNSI patients compared to remitting MS patients (Table 3). This evidence concerns the gene MMP2 and myeloid sarcoma.